Service & Software

Global Gut Microbiome Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2031

Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Gut Microbiome Testing Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Biomesight
Carbiotix
EasyDNA
Floré Microbiome Gut Test
Genetic Analysis
GUTolution
Invivo Healthcare
Jona
Kean Health
Microba
Ombre
Randox Health
Sun Genomics
Tiny Health
Viome
Segment by Type
Gene Sequencing-Based Testing Services
Culture-Based Testing Services
Metabolite-Based Testing Services
Segment by Application
Health Assessment
Disease Diagnosis and Treatment
Nutrition and Health Guidance
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Gut Microbiome Testing Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Gut Microbiome Testing Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Gut Microbiome Testing Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Gene Sequencing-Based Testing Services
1.2.3 Culture-Based Testing Services
1.2.4 Metabolite-Based Testing Services
1.3 Market Segmentation by Application
1.3.1 Global Gut Microbiome Testing Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Health Assessment
1.3.3 Disease Diagnosis and Treatment
1.3.4 Nutrition and Health Guidance
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gut Microbiome Testing Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Gut Microbiome Testing Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Gut Microbiome Testing Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Gut Microbiome Testing Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Gene Sequencing-Based Testing Services Market Size by Players
3.3.2 Culture-Based Testing Services Market Size by Players
3.3.3 Metabolite-Based Testing Services Market Size by Players
3.4 Global Gut Microbiome Testing Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Gut Microbiome Testing Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Gut Microbiome Testing Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Gut Microbiome Testing Service Market Size by Type (2020-2031)
6.4 North America Gut Microbiome Testing Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Gut Microbiome Testing Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Gut Microbiome Testing Service Market Size by Type (2020-2031)
7.4 Europe Gut Microbiome Testing Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Gut Microbiome Testing Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Gut Microbiome Testing Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Gut Microbiome Testing Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Gut Microbiome Testing Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Gut Microbiome Testing Service Market Size by Type (2020-2031)
9.4 Central and South America Gut Microbiome Testing Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Gut Microbiome Testing Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Gut Microbiome Testing Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Gut Microbiome Testing Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Gut Microbiome Testing Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Biomesight
11.1.1 Biomesight Corporation Information
11.1.2 Biomesight Business Overview
11.1.3 Biomesight Gut Microbiome Testing Service Product Features and Attributes
11.1.4 Biomesight Gut Microbiome Testing Service Revenue and Gross Margin (2020-2025)
11.1.5 Biomesight Gut Microbiome Testing Service Revenue by Product in 2024
11.1.6 Biomesight Gut Microbiome Testing Service Revenue by Application in 2024
11.1.7 Biomesight Gut Microbiome Testing Service Revenue by Geographic Area in 2024
11.1.8 Biomesight Gut Microbiome Testing Service SWOT Analysis
11.1.9 Biomesight Recent Developments
11.2 Carbiotix
11.2.1 Carbiotix Corporation Information
11.2.2 Carbiotix Business Overview
11.2.3 Carbiotix Gut Microbiome Testing Service Product Features and Attributes
11.2.4 Carbiotix Gut Microbiome Testing Service Revenue and Gross Margin (2020-2025)
11.2.5 Carbiotix Gut Microbiome Testing Service Revenue by Product in 2024
11.2.6 Carbiotix Gut Microbiome Testing Service Revenue by Application in 2024
11.2.7 Carbiotix Gut Microbiome Testing Service Revenue by Geographic Area in 2024
11.2.8 Carbiotix Gut Microbiome Testing Service SWOT Analysis
11.2.9 Carbiotix Recent Developments
11.3 EasyDNA
11.3.1 EasyDNA Corporation Information
11.3.2 EasyDNA Business Overview
11.3.3 EasyDNA Gut Microbiome Testing Service Product Features and Attributes
11.3.4 EasyDNA Gut Microbiome Testing Service Revenue and Gross Margin (2020-2025)
11.3.5 EasyDNA Gut Microbiome Testing Service Revenue by Product in 2024
11.3.6 EasyDNA Gut Microbiome Testing Service Revenue by Application in 2024
11.3.7 EasyDNA Gut Microbiome Testing Service Revenue by Geographic Area in 2024
11.3.8 EasyDNA Gut Microbiome Testing Service SWOT Analysis
11.3.9 EasyDNA Recent Developments
11.4 Floré Microbiome Gut Test
11.4.1 Floré Microbiome Gut Test Corporation Information
11.4.2 Floré Microbiome Gut Test Business Overview
11.4.3 Floré Microbiome Gut Test Gut Microbiome Testing Service Product Features and Attributes
11.4.4 Floré Microbiome Gut Test Gut Microbiome Testing Service Revenue and Gross Margin (2020-2025)
11.4.5 Floré Microbiome Gut Test Gut Microbiome Testing Service Revenue by Product in 2024
11.4.6 Floré Microbiome Gut Test Gut Microbiome Testing Service Revenue by Application in 2024
11.4.7 Floré Microbiome Gut Test Gut Microbiome Testing Service Revenue by Geographic Area in 2024
11.4.8 Floré Microbiome Gut Test Gut Microbiome Testing Service SWOT Analysis
11.4.9 Floré Microbiome Gut Test Recent Developments
11.5 Genetic Analysis
11.5.1 Genetic Analysis Corporation Information
11.5.2 Genetic Analysis Business Overview
11.5.3 Genetic Analysis Gut Microbiome Testing Service Product Features and Attributes
11.5.4 Genetic Analysis Gut Microbiome Testing Service Revenue and Gross Margin (2020-2025)
11.5.5 Genetic Analysis Gut Microbiome Testing Service Revenue by Product in 2024
11.5.6 Genetic Analysis Gut Microbiome Testing Service Revenue by Application in 2024
11.5.7 Genetic Analysis Gut Microbiome Testing Service Revenue by Geographic Area in 2024
11.5.8 Genetic Analysis Gut Microbiome Testing Service SWOT Analysis
11.5.9 Genetic Analysis Recent Developments
11.6 GUTolution
11.6.1 GUTolution Corporation Information
11.6.2 GUTolution Business Overview
11.6.3 GUTolution Gut Microbiome Testing Service Product Features and Attributes
11.6.4 GUTolution Gut Microbiome Testing Service Revenue and Gross Margin (2020-2025)
11.6.5 GUTolution Recent Developments
11.7 Invivo Healthcare
11.7.1 Invivo Healthcare Corporation Information
11.7.2 Invivo Healthcare Business Overview
11.7.3 Invivo Healthcare Gut Microbiome Testing Service Product Features and Attributes
11.7.4 Invivo Healthcare Gut Microbiome Testing Service Revenue and Gross Margin (2020-2025)
11.7.5 Invivo Healthcare Recent Developments
11.8 Jona
11.8.1 Jona Corporation Information
11.8.2 Jona Business Overview
11.8.3 Jona Gut Microbiome Testing Service Product Features and Attributes
11.8.4 Jona Gut Microbiome Testing Service Revenue and Gross Margin (2020-2025)
11.8.5 Jona Recent Developments
11.9 Kean Health
11.9.1 Kean Health Corporation Information
11.9.2 Kean Health Business Overview
11.9.3 Kean Health Gut Microbiome Testing Service Product Features and Attributes
11.9.4 Kean Health Gut Microbiome Testing Service Revenue and Gross Margin (2020-2025)
11.9.5 Kean Health Recent Developments
11.10 Microba
11.10.1 Microba Corporation Information
11.10.2 Microba Business Overview
11.10.3 Microba Gut Microbiome Testing Service Product Features and Attributes
11.10.4 Microba Gut Microbiome Testing Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Ombre
11.11.1 Ombre Corporation Information
11.11.2 Ombre Business Overview
11.11.3 Ombre Gut Microbiome Testing Service Product Features and Attributes
11.11.4 Ombre Gut Microbiome Testing Service Revenue and Gross Margin (2020-2025)
11.11.5 Ombre Recent Developments
11.12 Randox Health
11.12.1 Randox Health Corporation Information
11.12.2 Randox Health Business Overview
11.12.3 Randox Health Gut Microbiome Testing Service Product Features and Attributes
11.12.4 Randox Health Gut Microbiome Testing Service Revenue and Gross Margin (2020-2025)
11.12.5 Randox Health Recent Developments
11.13 Sun Genomics
11.13.1 Sun Genomics Corporation Information
11.13.2 Sun Genomics Business Overview
11.13.3 Sun Genomics Gut Microbiome Testing Service Product Features and Attributes
11.13.4 Sun Genomics Gut Microbiome Testing Service Revenue and Gross Margin (2020-2025)
11.13.5 Sun Genomics Recent Developments
11.14 Tiny Health
11.14.1 Tiny Health Corporation Information
11.14.2 Tiny Health Business Overview
11.14.3 Tiny Health Gut Microbiome Testing Service Product Features and Attributes
11.14.4 Tiny Health Gut Microbiome Testing Service Revenue and Gross Margin (2020-2025)
11.14.5 Tiny Health Recent Developments
11.15 Viome
11.15.1 Viome Corporation Information
11.15.2 Viome Business Overview
11.15.3 Viome Gut Microbiome Testing Service Product Features and Attributes
11.15.4 Viome Gut Microbiome Testing Service Revenue and Gross Margin (2020-2025)
11.15.5 Viome Recent Developments
12 Gut Microbiome Testing ServiceIndustry Chain Analysis
12.1 Gut Microbiome Testing Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Gut Microbiome Testing Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Gut Microbiome Testing Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Gut Microbiome Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Gut Microbiome Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Gut Microbiome Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Gut Microbiome Testing Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Gut Microbiome Testing Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Gut Microbiome Testing Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Gut Microbiome Testing Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Gut Microbiome Testing Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gut Microbiome Testing Service as of 2024)
Table 11. Global Gut Microbiome Testing Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Gut Microbiome Testing Service Companies Headquarters
Table 13. Global Gut Microbiome Testing Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Gut Microbiome Testing Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Gut Microbiome Testing Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Gut Microbiome Testing Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Gut Microbiome Testing Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. Gut Microbiome Testing Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Gut Microbiome Testing Service Growth Accelerators and Market Barriers
Table 25. North America Gut Microbiome Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Gut Microbiome Testing Service Growth Accelerators and Market Barriers
Table 27. Europe Gut Microbiome Testing Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Gut Microbiome Testing Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Gut Microbiome Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Gut Microbiome Testing Service Investment Opportunities and Key Challenges
Table 31. Central and South America Gut Microbiome Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Gut Microbiome Testing Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Gut Microbiome Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Biomesight Corporation Information
Table 35. Biomesight Description and Major Businesses
Table 36. Biomesight Product Features and Attributes
Table 37. Biomesight Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Biomesight Revenue Proportion by Product in 2024
Table 39. Biomesight Revenue Proportion by Application in 2024
Table 40. Biomesight Revenue Proportion by Geographic Area in 2024
Table 41. Biomesight Gut Microbiome Testing Service SWOT Analysis
Table 42. Biomesight Recent Developments
Table 43. Carbiotix Corporation Information
Table 44. Carbiotix Description and Major Businesses
Table 45. Carbiotix Product Features and Attributes
Table 46. Carbiotix Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Carbiotix Revenue Proportion by Product in 2024
Table 48. Carbiotix Revenue Proportion by Application in 2024
Table 49. Carbiotix Revenue Proportion by Geographic Area in 2024
Table 50. Carbiotix Gut Microbiome Testing Service SWOT Analysis
Table 51. Carbiotix Recent Developments
Table 52. EasyDNA Corporation Information
Table 53. EasyDNA Description and Major Businesses
Table 54. EasyDNA Product Features and Attributes
Table 55. EasyDNA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. EasyDNA Revenue Proportion by Product in 2024
Table 57. EasyDNA Revenue Proportion by Application in 2024
Table 58. EasyDNA Revenue Proportion by Geographic Area in 2024
Table 59. EasyDNA Gut Microbiome Testing Service SWOT Analysis
Table 60. EasyDNA Recent Developments
Table 61. Floré Microbiome Gut Test Corporation Information
Table 62. Floré Microbiome Gut Test Description and Major Businesses
Table 63. Floré Microbiome Gut Test Product Features and Attributes
Table 64. Floré Microbiome Gut Test Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Floré Microbiome Gut Test Revenue Proportion by Product in 2024
Table 66. Floré Microbiome Gut Test Revenue Proportion by Application in 2024
Table 67. Floré Microbiome Gut Test Revenue Proportion by Geographic Area in 2024
Table 68. Floré Microbiome Gut Test Gut Microbiome Testing Service SWOT Analysis
Table 69. Floré Microbiome Gut Test Recent Developments
Table 70. Genetic Analysis Corporation Information
Table 71. Genetic Analysis Description and Major Businesses
Table 72. Genetic Analysis Product Features and Attributes
Table 73. Genetic Analysis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Genetic Analysis Revenue Proportion by Product in 2024
Table 75. Genetic Analysis Revenue Proportion by Application in 2024
Table 76. Genetic Analysis Revenue Proportion by Geographic Area in 2024
Table 77. Genetic Analysis Gut Microbiome Testing Service SWOT Analysis
Table 78. Genetic Analysis Recent Developments
Table 79. GUTolution Corporation Information
Table 80. GUTolution Description and Major Businesses
Table 81. GUTolution Product Features and Attributes
Table 82. GUTolution Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. GUTolution Recent Developments
Table 84. Invivo Healthcare Corporation Information
Table 85. Invivo Healthcare Description and Major Businesses
Table 86. Invivo Healthcare Product Features and Attributes
Table 87. Invivo Healthcare Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Invivo Healthcare Recent Developments
Table 89. Jona Corporation Information
Table 90. Jona Description and Major Businesses
Table 91. Jona Product Features and Attributes
Table 92. Jona Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Jona Recent Developments
Table 94. Kean Health Corporation Information
Table 95. Kean Health Description and Major Businesses
Table 96. Kean Health Product Features and Attributes
Table 97. Kean Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Kean Health Recent Developments
Table 99. Microba Corporation Information
Table 100. Microba Description and Major Businesses
Table 101. Microba Product Features and Attributes
Table 102. Microba Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Microba Recent Developments
Table 104. Ombre Corporation Information
Table 105. Ombre Description and Major Businesses
Table 106. Ombre Product Features and Attributes
Table 107. Ombre Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Ombre Recent Developments
Table 109. Randox Health Corporation Information
Table 110. Randox Health Description and Major Businesses
Table 111. Randox Health Product Features and Attributes
Table 112. Randox Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Randox Health Recent Developments
Table 114. Sun Genomics Corporation Information
Table 115. Sun Genomics Description and Major Businesses
Table 116. Sun Genomics Product Features and Attributes
Table 117. Sun Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Sun Genomics Recent Developments
Table 119. Tiny Health Corporation Information
Table 120. Tiny Health Description and Major Businesses
Table 121. Tiny Health Product Features and Attributes
Table 122. Tiny Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Tiny Health Recent Developments
Table 124. Viome Corporation Information
Table 125. Viome Description and Major Businesses
Table 126. Viome Product Features and Attributes
Table 127. Viome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Viome Recent Developments
Table 129. Raw Materials Key Suppliers
Table 130. Distributors List
Table 131. Market Trends and Market Evolution
Table 132. Market Drivers and Opportunities
Table 133. Market Challenges, Risks, and Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources


List of Figures
Figure 1. Gut Microbiome Testing Service Product Picture
Figure 2. Global Gut Microbiome Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Gene Sequencing-Based Testing Services Product Picture
Figure 4. Culture-Based Testing Services Product Picture
Figure 5. Metabolite-Based Testing Services Product Picture
Figure 6. Global Gut Microbiome Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Health Assessment
Figure 8. Disease Diagnosis and Treatment
Figure 9. Nutrition and Health Guidance
Figure 10. Gut Microbiome Testing Service Report Years Considered
Figure 11. Global Gut Microbiome Testing Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Gut Microbiome Testing Service Revenue (2020-2031) & (US$ Million)
Figure 13. Global Gut Microbiome Testing Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Gut Microbiome Testing Service Revenue Market Share by Region (2020-2031)
Figure 15. Global Gut Microbiome Testing Service Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Gene Sequencing-Based Testing Services Revenue Market Share by Player in 2024
Figure 18. Culture-Based Testing Services Revenue Market Share by Player in 2024
Figure 19. Metabolite-Based Testing Services Revenue Market Share by Player in 2024
Figure 20. Global Gut Microbiome Testing Service Revenue Market Share by Type (2020-2031)
Figure 21. Global Gut Microbiome Testing Service Revenue Market Share by Application (2020-2031)
Figure 22. North America Gut Microbiome Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 23. North America Top 5 Players Gut Microbiome Testing Service Revenue (US$ Million) in 2024
Figure 24. North America Gut Microbiome Testing Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 25. North America Gut Microbiome Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 26. US Gut Microbiome Testing Service Revenue (2020-2031) & (US$ Million)
Figure 27. Canada Gut Microbiome Testing Service Revenue (2020-2031) & (US$ Million)
Figure 28. Mexico Gut Microbiome Testing Service Revenue (2020-2031) & (US$ Million)
Figure 29. Europe Gut Microbiome Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 30. Europe Top 5 Players Gut Microbiome Testing Service Revenue (US$ Million) in 2024
Figure 31. Europe Gut Microbiome Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 32. Europe Gut Microbiome Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 33. Germany Gut Microbiome Testing Service Revenue (2020-2031) & (US$ Million)
Figure 34. France Gut Microbiome Testing Service Revenue (2020-2031) & (US$ Million)
Figure 35. U.K. Gut Microbiome Testing Service Revenue (2020-2031) & (US$ Million)
Figure 36. Italy Gut Microbiome Testing Service Revenue (2020-2031) & (US$ Million)
Figure 37. Russia Gut Microbiome Testing Service Revenue (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Gut Microbiome Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Top 8 Players Gut Microbiome Testing Service Revenue (US$ Million) in 2024
Figure 40. Asia-Pacific Gut Microbiome Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 41. Asia-Pacific Gut Microbiome Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 42. Indonesia Gut Microbiome Testing Service Revenue (2020-2031) & (US$ Million)
Figure 43. Japan Gut Microbiome Testing Service Revenue (2020-2031) & (US$ Million)
Figure 44. South Korea Gut Microbiome Testing Service Revenue (2020-2031) & (US$ Million)
Figure 45. Australia Gut Microbiome Testing Service Revenue (2020-2031) & (US$ Million)
Figure 46. India Gut Microbiome Testing Service Revenue (2020-2031) & (US$ Million)
Figure 47. Indonesia Gut Microbiome Testing Service Revenue (2020-2031) & (US$ Million)
Figure 48. Vietnam Gut Microbiome Testing Service Revenue (2020-2031) & (US$ Million)
Figure 49. Malaysia Gut Microbiome Testing Service Revenue (2020-2031) & (US$ Million)
Figure 50. Philippines Gut Microbiome Testing Service Revenue (2020-2031) & (US$ Million)
Figure 51. Singapore Gut Microbiome Testing Service Revenue (2020-2031) & (US$ Million)
Figure 52. Central and South America Gut Microbiome Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Central and South America Top 5 Players Gut Microbiome Testing Service Revenue (US$ Million) in 2024
Figure 54. Central and South America Gut Microbiome Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 55. Central and South America Gut Microbiome Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 56. Brazil Gut Microbiome Testing Service Revenue (2020-2025) & (US$ Million)
Figure 57. Argentina Gut Microbiome Testing Service Revenue (2020-2025) & (US$ Million)
Figure 58. Middle East and Africa Gut Microbiome Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Middle East and Africa Top 5 Players Gut Microbiome Testing Service Revenue (US$ Million) in 2024
Figure 60. South America Gut Microbiome Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 61. Middle East and Africa Gut Microbiome Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 62. GCC Countries Gut Microbiome Testing Service Revenue (2020-2025) & (US$ Million)
Figure 63. Israel Gut Microbiome Testing Service Revenue (2020-2025) & (US$ Million)
Figure 64. Egypt Gut Microbiome Testing Service Revenue (2020-2025) & (US$ Million)
Figure 65. South Africa Gut Microbiome Testing Service Revenue (2020-2025) & (US$ Million)
Figure 66. Gut Microbiome Testing Service Industry Chain Mapping
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies